Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This Promo is for the US so you guys better get them here fast they are planning on millions of volume.
$IMEXF BIG Promo coming our way ! Get them while you can !
IMAGIN MEDICAL CLOSING FINANCING TO BROADEN COMMUNICATIONS PROGRAM
https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aIME-2520880&symbol=IME®ion=C
News highs on Canadian market 18.5 !! Volume 4.6 million
I was posting very early on this play.... but for those who missed LRTTF, I have another that just started FRRSF. Here is some DD
[urlhttps://www.prnewswire.com/news-releases/lithium-demand-is-front-and-center-once-again-651843983.html#][/url][tag]Lithium Demand is Front and Center Once Again[/tag]
http://rockstone-research.com/index.php/en/research-reports/3676-Great-Time-to-be-a-FAT-Shareholder" rel="nofollow" target="_blank" >http://rockstone-research.com/index.php/en/research-reports/3676-Great-Time-to-be-a-FAT-Shareholder[tag]Great Time to be a FAT Shareholder
Impressive Lithium Results on the Horizon (again) plus Spin-Out Shares[/tag]
If $lrttf $lby (I’m out) any indicator for #lithium demand some of these should fair well $fat https://t.co/uBfHrPuv86 pic.twitter.com/PrhKu6E1Ir
— Jason Spatafora (@WolfOfWeedST) October 24, 2017
The Lithium is all over the place the ground looks like a giant cake !!
See picture:
$FAT $FRRSF Outcrop of spodumene #Lithium Looking forward to assays !! The whole area looks like Lithium Cake ! @BigBirdofBayst pic.twitter.com/yV2KIgYmsz
— CapitalGains (@CUUVETTE350) October 24, 2017
Looks like some Big marketing in the works = Volume = Higher prices !!
FAR RESOURCES EXPANDS COMMUNICATIONS PROGRAM
Far Resources Ltd. has completed a financing to raise money for the company's communications program.
https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aFAT-2517449&symbol=FAT®ion=C
Lithium Demand is Front and Center Once Again
LOS ANGELES, October 20, 2017 /PRNewswire/ --
As Ford signs a new deal for electric cars in China, demand for lithium is in the spotlight once again and these 4 Canadian companies are positioned to capitalize. Companies engaged in lithium exploration, production, and refining include Nemaska Lithium (TSX: NMX) (OTC: NMKEF), Lithium Americas Corp. (TSX: LAC) (OTC: LACDF), Critical Elements Corp. (OTC: CRECF) (TSX-V: CRE), and Far Resources Ltd. (CSE: FAT) (OTC: FRRSF).
Lithium has been aptly labeled the "new gasoline" by Goldman Sachs as demand for the metal continues to outpace supplies.
The expansion of the electric vehicle (EV) market is expected to be a key factor in the rising demand. Clearly Ford Motor's new deal to produce electric vehicles in China adds another level to the already heavy demand being placed on the lithium industry.
That's in addition to Tesla's new Gigafactory in Nevada, which is expecting to produce enough lithium ion batteries to power 500,000 electric cars per year by 2020.
There are some promising lithium companies positioned to be suppliers of the world's new energy source of choice.
Canada's group of lithium focused mining companies promise to be some of the first suppliers to take up the slack.
One that's moving full speed ahead is FAR Resources Ltd. (CSE: FAT.CN) (OTC: FRRSF), which has a solid legacy of production based on its "historical" resource of high quality lithium in the province of Manitoba.
Other Canadian mining firms are also working furiously to tap the reserves for valuable lithium. These include Nemaska Lithium Inc. (TSX: NMX.TO) (OTCQX: NMKEF), the Quebec-based company focused on its new Whabouchi lithium project and establishing refining operations, along with Lithium Americas Corp. (TSX: LAC.TO) (OTCQX: LACDF), that has large-scale lithium carbonate production with its partner and industry giant, Chile's SQM, and Critical Elements Corp. (TSX.V: CRE.V) (OTCQX: CRECF), whose Rose project in Quebec offers a low-risk jurisdiction with expected production by 2021.
MORE, MORE, MORE
Demand for lithium, the silvery-white metal labelled "the new gasoline", rose 26% in 2016 and is predicted to climb another 39% in 2018. By 2025, demand is projected to increase by 73% as electric vehicles become more accessible and an increasing number of countries, including massive new players like China, tighten restrictions on petroleum powered vehicles.
Last year, the top 13 battery makers boasted annual production capacity of 29 gigawatt-hours (GWh) of energy-storage products. By 2020, those same companies are expected to grow production capacity to 171 GWh. Tesla's first $5 billion Gigafactory represents roughly 35 GWh.
Macquarie estimates global demand is currently about 184,500 tons, and it's slated to rise to more than 260,000 tons in 2020. But, it could end up being much greater based on the additional new demands.
Rising demand and prices for the top two lithium products -- lithium carbonate and lithium hydroxide -- have driven revenue, income, and shares higher for both the world's top lithium producers, and higher share prices for smaller companies entering the space in order to increase supplies of lithium from existing reserves or new discoveries.
QUALITY OVER QUANTITY
There are two types of lithium processing: through hard rock ore, which is mined like other metals in Australia and Canada, or through a salt water brine, most prevalent in South America's "lithium triangle" of Bolivia-Chile-Argentina.
That area holds an estimated 70 per cent of known reserves of lithium.
Hard rock ore, produces higher purity lithium and holds greater potential to be directly processed into lithium hydroxide, the type required for batteries.
Currently, lithium must be processed from lithium carbonate, which is used for medical and industrial applications that comprise the bulk of the demand for lithium.
Far Resources is one of the Canadian companies fully invested in creating new hard rock (high purity) lithium resources.
FAR RESOURCES' LEGACY
In the pure lithium category, Far Resources Ltd. ranks high.
Far Resources a junior mining company that has secured a potential major lithium resource. The company's Zoro Lithium property near Snow Lake, Manitoba covers a significant lithium pegmatite occurrence that contains a historic "reserve" based on 1956 drilling of 1.8 million tonnes grading 1.4% Li2O to a depth of 1000 feet.
In simple terms, that figure represents a lot of very high grade lithium potential.
By the industry regulations, Far Resources cannot treat the historical estimate as current mineral resources or mineral reserves as defined by national mining regulations. But that limitation may be replaced by new data from samples and drilling meant to validate the existing information.
Far Resources has begun a full exploration program with sophisticated mining technology on their Snow Lake property yielding results that look very promising.
Success in that low-risk and very productive mining region could quickly put Far Resources right on track with leading lithium producers, and add tremendously to the company's value.
A NEW FRONTIER
The ramp-up of lithium-ion battery manufacturing facilities in the next several years will need to be matched by an equal ramp-up of lithium supply from a range of producers - both in the brine and hard rock space.
Just how much lithium will actually be required remains unknown.
Macquarie estimates global demand is currently about 184,500 tons, and it's slated to rise to more than 260,000 tons in 2020.
Metals and minerals consultancy Roskill Information Services provides a similar estimate, with its base scenario for lithium consumption at 290,000 tons in 2020. However, that figure rises to a sizeably larger 420,000 tons in what it calls its "optimistic" scenario.
And things are continuing to look very optimistic in this space, especially when major automakers like Ford, BMW and Volvo kick in with major demands from new markets including China.
There is little doubt that there will be a significant shortfall, based on current reserves and slated new production.
This is where the existing lithium producers, and newcomers alike have the opportunity to capture a windfall.
Most of these companies are investing major capital and enormous resources in the rush to answer the demands. At the same time, exploration and development companies like Far Resources are opening the potential for whole new opportunities that were previously left dormant.
A most likely place to look for the emerging lithium appears to be opportunities is in low-risk mining jurisdictions like Canada, with experienced miners tapping historically productive lithium zones.
POTENTIAL COMPARABLES
Nemaska Lithium Inc. (TSX: NMX.TO) (OTCQX: NMKEF)
Nemaska Lithium intends to become a lithium hydroxide supplier and lithium carbonate supplier to the emerging lithium battery market that is largely driven by electric vehicles, cell phones, tablets and other consumer products. The Corporation is developing in Quebec one of the most important spodumene lithium hard rock deposit in the world, both in volume and grade. The spodumene concentrate produced at Nemaska Lithium's Whabouchi mine will be shipped to the Corporation's lithium compounds processing plant to be built in Shawinigan, Quebec. This plant will transform spodumene concentrate into high purity lithium hydroxide and carbonate using the proprietary methods developed by the Corporation, and for which patent applications have been filed.
Lithium Americas (TSX: LAC.TO) (OTCQX: LACDF)
Lithium Americas, through a Joint Venture with Sociedad Química y Minera de Chile (SQM), is developing the Cauchari-Olaroz brine deposit in Jujuy, Argentina. Through its wholly-owned subsidiary, Lithium Nevada Corp., the company is developing one of North Americas' largest lithium deposits in northern Nevada*. The company intends to become a major supplier of lithium products to the energy storage and electrified vehicle markets. In addition, through its wholly-owned subsidiary RheoMinerals Inc., Lithium Americas is a supplier of specialty drilling additives and other organoclay products for the oil and gas, agricultural, and other industries.
Critical Elements Corp. (TSX-V: CRE.V) (OTCQX: CRECF)
Critical Elements Corporation is a mining exploration company owning several mining properties in Quebec. The Company is focused on the rare earths, particularly lithium. It has achieved its objective with the Rose lithium-tantalum project, which is currently at the advanced exploration stage. Based on the work programs developed and positive results, Critical Elements Corporation is aiming to put the Rose lithium-tantalum project into production rapidly. The Company flagship project is well located in Quebec with on-site access to infrastructures like: powerline, road, airport, railway access and camp. The project hosts a current Indicated resource of 26.5 million tonnes of 1.30% Li2O Eq. or 0.98% Li2O and 163 ppm Ta2O5 and an Inferred resource of 10.7 million tonnes of 1.14% Li2O Eq. or 0.86% Li2O and 145 ppm Ta2O5.
For a more in-depth look into FAR you can view the in-depth report at USA News Group: http://usanewsgroup.com/2017/10/16/analysts-agree-lithium-upswing-3-2/
Buyout before any FDA anything ! Watch !
The Medical Device Market Just Keeps Going Strong
LOS ANGELES, October 23, 2017 /PRNewswire/ --
USA News Group - In spite of lawmakers' inability to determine direction for healthcare, medical device companies continue to be some of the strongest performers this year. Companies being rewarded for their consistency outside the fray include Baxter International, Inc. (NYSE: BAX), Becton, Dickinson and Co. (NYSE: BDX), Boston Scientific Corp. (NYSE: BSX), and Imagin Medical Inc. (CSE: IME) (OTC: IMEXF).
During a period when the big tech companies appear to rule the day, several medical device and technology companies have been quietly making fortunes.
Some of the best stocks in this space have been up all year, with the leaders reflecting their strong fundamentals' performance and providing investors with great returns.
There seems to be a consensus among market gurus that there is no reason for this to end at the moment and these still have room to run.
This is very evident in some top drawer companies; three that you know well and one you will not likely have heard about, but that could really shake up the medical imaging space.
The small player in the group is gaining interest for its new, patented technology for use in medical imaging targeting bladder cancer. Imagin Medical Inc., (CSE: IME) (OTC: IMEXF) is heading into human testing with its i/Blue™ cancer imaging technology and offers major promise for that dread disease.
The three others who have been delivering on fundamentals have been deemed the "Killer B's" for their momentum despite a US healthcare market in flux. They are Baxter International, Inc. (NYSE: BAX), which makes medical equipment like dialysis machines and infusion systems, along with Becton, Dickinson and Co. (NYSE: BDX) that makes supplies like needles, syringes and catheters, and Boston Scientific Corp. (NYSE: BSX), which makes pacemakers and defibrillators, among other cardiovascular and endoscopic devices.
Each of these three has rallied into the double-digits in 2017.
Medical Device Market Cruising
At a time when nearly all market sectors are feeling the impact of global turmoil, the medical device market seems to keep cruising. It's a great place to be right now.
Spending on medical devices is expected to reach $176 billion this year in the Americas and nearly $360 billion worldwide. The US is estimated to spend about $4.5 billion per year on medical and diagnostic imaging alone.
The diagnostic imaging segment has seen continual growth based on the increasing number of patients, as well as an increasing demand for minimally invasive surgery, which requires precise imaging.
The overall U.S. healthcare market grows at a regular rate of about 5.6 percent annually and is expected to reach nearly 20% of the U.S. GDP by 2015 or total spending of $3.4 trillion in 2016.
According to the Advisory Board 2017 report, the increases are brought about by changes in economic growth and population aging and not as much by changes in insurance coverage.
Based on the size and scale of this market, it's easy to see why there continues to be significant opportunities in the medical device space.
Imagin Medical Targets the Most Expensive Form of Cancer
An emerging innovator in this group is looking to emulate the success of the major providers by targeting a very large market: bladder cancer.
Imagin Medical is the developer of the i/Blue™ Imaging System to help detect bladder cancer and reduce its recurrence by dramatically improving the urologist's ability to visualize, identify and then remove cancerous cells.
Bladder cancer is the most expensive form of cancer to treat, accounting for cumulative costs of $4 billion or about 3.2% of all cancer care each year. It is the sixth largest market for cancer treatment and yet treatment approaches have not really changed over the past 25 years.
Imagin's system uses endoscopic technology combined with white light and video imaging to visualize the human bladder in order to detect cancer. This is combined with fluorescing drugs and specialized blue light imaging to improve the visualization of tumors many times over.
The results are dramatic.
According to the company, Imagin's i/Blue™ system increases sensitivity for detecting the cancer specific contrast agent by 5 orders of magnitude or 100,000X.
Cheaper, Faster, Better
A new technology that radically transforms the way things are done in medical imaging and diagnostics, Imagin's i/Blue™ system could well be classified as disruptive. There are several aspects that set it apart from anything available today.
First, Imagin's approach allows the system to accurately image in less than 15 minutes vs. the one-hour period required to metabolize drugs using conventional fluorescing system.
Second, its computer application cleans, reprocesses, blends and displays the image of the bladder and cancer onto a single monitor at the same time. This allows for multiple perspectives of the bladder on a single system, as opposed to switching between white to blue light systems.
Last, the i/Blue™ system's advancement in sensitivity improves surgeons' ability to detect even flat cancers and to visualize their margins for more complete removal. This can dramatically reduce the risk of recurrence, slowing the progression of the disease
What's really exciting about the i/Blue™ System is its ability to improve results, simplify procedures, save time and money.
Not Holding Back
There is still plenty of room for innovation in the medical device market. There also appears plenty of room for solid companies to profit richly in this space.
The leaders in the group continue to flourish, and regardless of failed promises of Washington to deliver tax breaks that would help the industry, stay profitable.
Some of these stocks might look relatively expensive now, but there's a good chance investors will look back at these prices similar to the way tech sector stocks that are going off the charts are viewed now.
If Baxter, B&D and Boston Scientific look expensive, consider Imagin Medicals unique position: despite all its early advances, the company appears undervalued at a meager $5 million market cap.
Although it is an emerging medical company, IME has already made great progress. Launched in 2016, it has finished its prototype and moved into human testing to be carried out at University of Rochester Laboratory for Laser Energetics (LLE). This could result in the next major step and heading into commercialization.
Be on the lookout for IME join the list of the elite innovators adding disruptive technology to the medical imaging and diagnostic space.
Potential Comparables
Baxter International, Inc. (NYSE: BAX)
Baxter International Inc. provides a portfolio of renal and hospital products. The company operates through two segments, Hospital Products and Renal. The Hospital Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics, and biosurgery products. This segment also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies. The Renal segment provides products to treat end-stage renal disease, irreversible kidney failure, and acute kidney therapies. The company sells its products for use in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision.
Becton, Dickinson and Co. (NYSE: BDX)
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. It operates in two segments, BD Medical and BD Life Sciences. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry, and general public. It has a strategic collaboration with FlowJo, LLC. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Boston Scientific Corp. (NYSE: BSX)
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg. The company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; other coronary therapy products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels; and structural heart therapy systems and products to diagnose and treat diseases of the pulmonary and gastrointestinal conditions; devices to diagnose, treat, and ease pulmonary disease systems within the airway and lungs; and spinal cord stimulator systems for the management of chronic pain. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
For a more in-depth look into IME you can view the in-depth report at USA News Group: http://usanewsgroup.com/2017/10/22/checkpoint-inhibitors-show-promise-in-bladder-cancer-2-2/.
http://usanewsgroup.com
info@usanewsgroup.com
News! Imagin releases i/Blue imaging trial patient criteria
2017-10-19 11:33 ET - News Release
Mr. Jim Hutchens reports
IMAGIN MEDICAL ANNOUNCES CLINICAL RESEARCH CRITERIA 10.19.17
Imagin Medical Inc. has released the recruitment criteria for the upcoming research study at the University of Rochester Medical Center.
The pilot study, entitled Near Infrared Fluorescence Imaging for Bladder Cancer Detection, is sponsored by Dr. Edward Messing, chair of urology at the University of Rochester Medical Center, and the study's principal investigator. The study is registered on the National Institutes of Health (NIH) website.
Criteria to participate in the study include men and women 18 years or older, of either sex and any racial or ethnic origin, who are scheduled for a transurethral resection of bladder tumor (TURBT) in the operating room resulting from either a new diagnosis of a potentially malignant bladder mass or a recurrent tumor.
The procedure to remove the suspicious mass will remain the same, that is, TURBT; it is the method to detect the cancerous cells to be removed that will differ significantly. The i/Blue imaging system is expected to highlight the cancerous cells in less than 10 minutes versus the full hour required by current systems, leading to a substantial reduction in the time and cost of staff and facilities.
And we have Insider buying today @15 and 16 cents
Here's a picture of the filling on sedi
$ime $imexf Insider buying 135K today 15 and 16. Filed on SEDi today (see pic), view on canadian insider tomorrow. pic.twitter.com/WmBVc8CKMw
— CapitalGains (@CUUVETTE350) October 17, 2017
$IMEXF Small Medical Wonders Hold Promise for Big Profits
Huge bids coming on Canadian market
1 300000 0.160 0.165 224000 5
8 552000 0.155 0.170 399500 9
10 1015500 0.150 0.175 117000 5
New 52 week High on the Canadian market, big volume !!
$IMEXF PP closed !!
IMAGIN MEDICAL CLOSING SECOND AND FINAL TRANCHE OF $1,000,000 PRIVATE PLACEMENT
"The success of this private placement speaks volumes about the confidence our investors have in our technology and the future of the company in the marketplace," said Jim Hutchens, Imagin's president and chief executive officer.
https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aIME-2515740&symbol=IME®ion=C
This is going wayyy higher guys. PP closes any day now. I expect tomorrow and then its go time !!
40.5 metres of Spodumene
This is a step out! Area has never been drilled
Their avg is 1.2% lithium
Market cap cheap if they have a couple million tons of lithium.
Results coming!
We have Lithium !!
https://www.stockwatch.com/News/Item.aspx?bid=U-fsx00020171-U%3aFRRSF-20171011&symbol=FRRSF®ion=U
Far Resources Completes Drill Program and Intersects up to 40.5 metres of Spodumene Pegmatite in Dyke 1, Zoro Lithium Property, Manitoba
IMEXF Great News !
http://m.marketwired.com/press-release/-2236821.htm
Urologists Invest in Imagin Medical Private Placement
magin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive surgery; The Company's initial focus is bladder cancer
VANCOUVER, BC and BOSTON, MA--(Marketwired - October 11, 2017) - Imagin Medical, Inc. (CSE: IME) (OTC PINK: IMEXF) (FRANKFURT: DPD2) (the "Company") announced on September 27 that the Company received approval from the University of Rochester for the upcoming first in-human Research Study using the i/Blue Imaging System to detect bladder cancer. The of closing of Tranche I of Imagin's recently announced and oversubscribed Private Placement further advances the Company's on-going development plan. Investors in this Private Placement include urologists Dr. Stan Swierzewski, Chief of Surgery & Director of Urology at Holyoke Medical Center in Massachusetts, and Dr. Roger Buckley, Division Head of Urology at North York General Hospital in Toronto.
Dr. Stanley J Swierzewski offered the following comments: "As a practicing urologist, I invested in Imagin because I have a duty and responsibility to advance any improvements in treatment and technology that will benefit my patients and save lives. Current technology is cumbersome and time consuming, taking a full hour of prep time as opposed to 10 minutes, making it less effective as a screening or follow-up tool. Bladder cancer patients are basically monitored for life with in-office cystoscopies which are not effective in differentiating between inflammation and cancer. To be safe, we perform surgery on many patients which often turns out to be negative. Imagin's i/Blue technology, given its potential speed and sensitivity, will help us assess the patient's condition more quickly and accurately and avoid unnecessary surgery. It will also make necessary surgery more successful, ultimately saving lives and reducing medical expenses. I'm confident that using the i/Blue system will become the standard of care. I look forward to the Research Study results and I cannot wait to use this technology in treating my bladder cancer patients."
"We're thrilled that practicing urologists see the value in our technology and are eager to use it in their practices," commented Jim Hutchens, Imagin Medical's President and CEO.
IMEXF is only 6 million market cap. So many companies that have nothing are trading at 30-50+. We should at minimum be 20 million market cap at this stage with what we have.
So yes 35 cents is coming !!
It's coming ! 4.4 Million volume on Canadian side. Same volume on US side is the goal. 25 cents coming.
At 7 million market cap this is very undervalued !!
Approved for DTC
http://www.marketwired.com/press-release/imagin-medical-begins-trading-on-otc-cse-ime-2119220.htm
The Company's common shares have been approved for DTC (Depository Trust Company) eligibility that allows Imagin Medical's securities to be deposited electronically through DTC, the largest securities depository in the world, with over $35 trillion worth of securities on deposit.
4.4 Million volume on Canadian side. Looking good.
https://www.stockwatch.com/Quote/Detail.aspx?symbol=IME®ion=C
Nice article on $IMEXF
http://aheadoftheherd.com/Newsletter/2016/Imagin-Medical.htm
$IMEXF RESEARCH STUDY LISTED ON GOVERNMENT WEBSITE expects study to confirm bench test results
https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aIME-2513098&symbol=IME®ion=C
The information about the coming clinical research study at the University of Rochester announced in a press release on Sept. 27, 2017, can be found on a government website maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH).
The pilot study entitled, Near Infrared Fluorescence Imaging for Bladder Cancer Detection, is sponsored by Dr. Edward Messing, Chair of Urology at the University of Rochester Medical Center, and the study's principal investigator. The primary purpose of the study is to determine the minimal dwell time needed for adequate detection of cancerous cells using protoporphyrin IX (PpIX) near infrared fluorescence (NIRF). Imagin anticipates the study will prove that surgeons will be able to "see" the cancerous cells in less than 15 minutes, one of the key features of the i/Blue technology. The Study will also evaluate another feature of the i/Blue System, the patented Simultaneous Acquisition of Differing Images, which will blend the white light and fluorescing images into one, enabling the surgeon, in one step, to identify the precise location of the of the cancerous cells within the bladder.
"We're eager for this study to begin," commented Jim Hutchens, Imagin Medical's President and CEO. "We expect the outcome to confirm our bench test results and build on the company's momentum."
The NIH database contains information about medical studies in human volunteers for both federally and privately funded trials, describing the purpose of the studies conducted in all 50 States and in 197 countries. Each study record presents summary information about the study protocol, including the medical product, behavior, or procedure being studied, as well as requirements for participation and study outcomes.
http://www.stockhouse.com/news/press-releases/2017/10/05/novateqni-receives-request-for-proposal-for-blockchain-solution
NEWS ! NovaTeqni Receives Request For Proposal For Blockchain Solution
Calgary, Alberta / TheNe wswire / October 5, 2017 – NovaTeqni Corporation (“ NovaTeqni ” or the " Company ") (TSXV - NTQ: OTCQB - NVTQF) is pleased to announce that the first version of the blockchain Farmers Management System is being proposed to an African country that requested that the Company submit a proposal based on the success of the system in Malawi.
Representatives flew to South Africa to see a demonstration of the Farmers Management System in operation and requested a formal proposal submitted as soon as possible.
The Farmers Management System originally launched in Malawi, includes government quality biometrics, fixed offices, wireless and land line communications, cloud based computing, and mobile biometrics systems.
Farmers were issued secure contactless smart cards containing biometrics data to allow instant identification. The system contains administrative functionality such as financial reporting and crop related reporting which led to an improvement in efficiency and capability within the important farming sector
The new blockchain based system will be customizable to work for different standard and non-standard product applications such as Know Your Client, student registration, access control, time and attendance, health plans, driver’s licences, voter validation, voter registration, and money transfers.
The newly proposed Farmers Management System will have distributed ledger smart contracts (blockchain) as the core of its technology. The Blockchain Farmers Management System is a practical example of where blockchain can be used and be monetized.
Further to the Company’s press release dated October 3, 2017, the Company has secured a non-dilutive funding partner.
Gerhard Mynhardt, CEO of Novateqni stated , “Blockchain is the perfect application when it comes to Farmers Management systems. Having this opportunity is just another affirmation that we are on the right track. We see only growth in this area for other applications.”
Highest US volume to date !
https://www.stockwatch.com/Quote/Detail.aspx?symbol=IMEXF®ion=U
Expect HUGE volume coming our way.
Record date for FRRSF should be around Dec 7th. IMO spin out will be 1 share of Gold company for 5 shares of FRRSF. IPO could be .50+ ,
I<ve see it before recently with another gold project but this one is apparently way better.
DTC coming for FRRSF very shortly !
Far Resources to seek shareholder OK for spinout
2017-10-04 09:33 ET - News Release
Mr. Keith Anderson reports
FAR RESOURCES PROVIDES UPDATE ON PLAN OF ARRANGEMENT
Far Resources Ltd. has provided an update on its previously announced plan of arrangement.
All shareholders of record as of Oct. 20, 2017, will be entitled to vote on a special resolution approving the plan of arrangement at an annual general and special meeting to be held on Tuesday, Dec. 5, 2017. Details of the plan of arrangement will be provided in a management information circular that will be mailed to all eligible Far Resources shareholders in November.
Upon completion of the plan of arrangement, eligible Far Resources shareholders will hold shares in two companies: Far Resources, which will be dedicated to advancing the Zoro lithium property, and a new company (SpinCo), which will pursue the Winston gold project located in Sierra county, New Mexico. Upon completion of the plan of arrangement, each eligible Far Resources shareholder will hold one Far Resources share in the capital of the company and a pro rata share of the SpinCo shares to be distributed under the plan of arrangement based on a conversion factor to be determined.
Following the meeting, the board of directors of Far Resources will set a share distribution record date to determine those shareholders who will receive the SpinCo shares. As of the share distribution record date, each Far Resources shareholder will receive his or her pro rata share of the common shares in SpinCo subject to the conversion factor and, at the same time, will continue to hold the same number of Far Resources shares that they held prior to the plan of arrangement.
After the plan of arrangement, shareholders of Far Resources will hold an interest in two operating companies and will benefit from the company's plan to list the SpinCo shares on a stock exchange that will ultimately provide shareholders the opportunity to realize the benefit of additional liquidity in their investments.
The plan of arrangement is subject to approval by the company's shareholders at the meeting. It will also be subject to court and regulatory approval. The company will provide full details of the plan of arrangement in the information circular that will be mailed to eligible shareholders and will be made available on SEDAR. Further details will be provided to shareholders and other stakeholders by news releases.
The company also announces that it will issue 10,000 common shares in the equity of the company at a deemed price of 30 cents per share to an outside consultant who is assisting the company with the implementation of the plan of arrangement.
About Far Resources Ltd.
Far Resources, an exploration company focused on the identification and development of high-potential mineral opportunities in stable jurisdictions, has two option agreements in place. The Zoro lithium property covers a number of known lithium pegmatite occurrences and is located near Snow Lake, Man. The second option is on the Winston property in New Mexico, United States. Far Resources has optioned its wholly owned Tchentlo Lake property in British Columbia, Canada, to Alchemist Mining Inc.
$IMEXF getting same marketing plan as $GLNNF
IMEXF already DTC eligible now !! We shouldn<t even be 6 million market with Human trials about to start !!
$NVTQF 1st BLOCKCHAIN VERTICAL (TOBACCO !)
NovaTeqni to Incorporate Blockchain into Farmers Management System
This new blockchain in NTQ's 1st vertical i l inked to the goverment of Malawi (Tobacco Farming Industry)
http://www.biometricupdate.com/201509/novateqni-to-develop-biometrics-solution-for-malawi-tobacco-farming-industry
September 10, 2015 -
Biometrics and secure payment technologies firm NovaTeqni Corporation announced that it has won a contract to develop, supply and maintain an advanced biometrics enabled system for the Southeast African country of Malawi’s tobacco farming industry
And we know they are looking at Cannabis per recent update:
http://www.otcmarkets.com/ajax/showNewsReleaseDocumentById.pdf?id=25716
Novateqni also delivered Phase 1 of the biometrics enabled Farmers Management System (“FMS”) which is used in the Tobacco industry
The cloud based FMS system has a number of applications within the agricultural and similar regulated sectors. Marketing of the system will now commence in other countries for various agricultural applications as well as for use in the cannabis industry.
$NVTQF Biometrics Infusion into Blockchain Technology is Pushing Mobile Payments and Bitcoin Industries to New Levels
http://www.prnewswire.com/news-releases/biometrics-infusion-into-blockchain-technology-is-pushing-mobile-payments-and-bitcoin-industries-to-new-levels-648204543.html
19 Industries The Blockchain Will Disrupt
Frank Holmes talking Blockchain, mentions U.S. Global Investors investing in HIVE. Not a pump for HIVE, I missed it, not missing NTQ. The second link is a two minute vid on how Blockchain works.
https://smallcappower.com/videos/videos-top-stories/blockchain-technology-companies/
Most recent $NVTQF Financing was done @ 60 cents. They don<t just give shares away, thus the tight float
CALGARY, ALBERTA, / ACCESSWIRE / NovaTeqni Corporation (NTQ.V) (NVTQF)
("NovaTeqni or the "Corporation") announces that it has completed the second tranche of a non-brokered private placement of units (each, a "Unit"). NovaTeqni issued an aggregate of 117,000 Units at a price of $0.60 per Unit for gross proceeds of $70,200.00. Each Unit consists of one common share in the capital of NovaTeqni (a "Common Share") and one-half of one common share purchase warrant (a "Warrant"). Each whole Warrant may be exercised to acquire one Common Share at a price of $1.00 per share for a period of 12 months from the date of issuance of the Warrant provided, however, if the volume weighted average closing price of the Common Shares exceeds $1.25 per share for more than 10 consecutive trading days, NovaTeqni may accelerate the Warrant exercise period to a date which is 30 calendar days following the date a press release is issued by NovaTeqni announcing the reduced Warrant exercise period. All of the securities issued under the private placement are subject to a four month hold period.
$NVTQF 101
So as you have read, Blockchain is going to disrupt many different industries, Voting, Goverment, Law, Healthcare, Agriculture, Biometrics. Entertainment, Media etc...
Here's where things get interesting... NTQ has fingers in all these industries and very powerful partners.
This is not a mining company going into the a new hot space, these guys have been at it for a while.
ABOUT NTQ:
NTQ (10 million market cap, 32 Million shares, CEO owns 13.5 Million) is a Biometrics and Secure Payment Technologies firm
As a technology-based firm with a focus on biometrics and secure payment technologies, Novateqni provides integrated software and hardware products for voter validation, voter registration, financial transactions and biometric requirements.
The company has corporate offices in Calgary, Alberta, sales offices in Norfolk, Virginia, a technical and development facility in Johannesburg, South Africa and manufacturing capacity in Hong Kong.
PARTNERS ?
In bed with :
Novus Holdings is a 2.5 Billion pound company
Novus being a sub of Naspers (96 Billion) one of the largest Tech companies in the worls.
Industries NTQ is active in:
VOTING
NovaTeqni and Naspers Subsidiary Novus Team to Provide Voter Registration Solution
http://www.marketwatch.com/story/novateqni-and-naspers-subsidiary-novus-team-to-provide-voter-registration-solution-for-united-nations-contract-in-liberia-2016-12-14
The lead and financial partner on this project is Novus Holdings which is a subsidiary of Naspers Limited ("Naspers").
Gerhard Mynhardt, CEO of Novateqni stated, "Naspers is a global internet and entertainment group and one of the largest technology investors in the world. Founded in 1915, Naspers now operates in more than 130 countries and markets with long-term growth potential. Naspers runs some of the world's leading platforms in internet, video entertainment and media. We are very pleased to be able to establish a relationship with Naspers by working with Novus. We look forward to expanding on our current relationship in the future."
Ok so we have very rich and powerful tech partners....
So we have experience in the Gov Voting sector, 1 of the main disruptive sectors for Blockchain.
10. Voting
Probably one of the most important areas of society that the blockchain will disrupt is voting. The 2016 US election is not the first time certain parties were accused of rigging election results. Blockchain technology can be used for voter registration and identity verification, and electronic vote counting to ensure that only legitimate votes are counted, and no votes are changed or removed. Creating an immutable, publicly-viewable ledger of recorded votes would be a massive step toward making elections more fair and democratic. Democracy Earth and Follow My Vote are two startups aiming to disrupt democracy itself through creating blockchain-based online voting systems for governments.
http://futurethinkers.org/industries-blockchain-disrupt/]http://futurethinkers.org/industries-blockchain-disrupt/
AGRICULTURE & TOBACCO
Novateqni to Develop Biometric System for Malawian Agriculture
Biometrics and secure payment technology developer Novateqni has won a major new contract for a large-scale deployment, the company has announced. It’s going to provide a Farmers Registration and Administration System for the Malawi government.
https://findbiometrics.com/novateqni-biometric-system-malawi-29115/
NovaTeqni to develop biometrics solution for Malawi tobacco farming industry
http://www.biometricupdate.com/201509/novateqni-to-develop-biometrics-solution-for-malawi-tobacco-farming-industry
TELECOM:
MTN Nigeria orders $1M in biometrics-based KYC devices from Novateqni
The KYC100 units are used to enroll the fingerprints, photo and personal detail of mobile phone buyers as required under the country’s new regulations.
The KYC notation, which stands for “Know Your Customer”, is the business process necessary to verify the identity of its clients, which is becoming increasingly important to prevent identity theft, financial fraud, money laundering and terrorist financing.
HEALTH CARE AND LAW
http://www.marketwatch.com/story/novateqni-receives-custom-biometrics-product-order-for-the-united-states-of-america-2017-08-08
NovaTeqni Receives Custom Biometrics Product Order For The United States Of America
Calgary-based NovaTeqni has been contracted to provide biometric technology for New Jersey-based enterprise mobile solutions provider Mobizent.
August 8, 2017 / TheNewswire / Calgary, Alberta - NovaTeqni Corporation ("NovaTeqni" or the "Company") (tsxv - ntq:OTCQB - NVTQF) is pleased to announce that the company has entered into a manufacturing, development and sales agreement with Mobizent LLC for the manufacturing and sale of the new MobiCHKII(TM) rugged mobile biometrics handheld computer intended for the federal sector in the USA.
Additionally, NovaTeqni will also develop and supply the MobiCONNECT(TM) device for Mobizent. These biometrics enabled handheld devices are used within the Law Enforcement, Public Safety, Border Patrol, Corporate Security Operations, Event Security, Refugee Control as well as Health Care sectors.
CANNABIS
Novateqni also delivered Phase 1 of the biometrics enabled Farmers Management System (“FMS”) which is used in the Tobacco industry
The cloud based FMS system has a number of applications within the agricultural and similar regulated sectors. Marketing of
the system will now commence in other countries for various agricultural applications as well as for use
in the cannabis industry.
http://www.otcmarkets.com/ajax/showNewsReleaseDocumentById.pdf?id=25716
Now NTQ looking to incorporate Blockchain.....
NovaTeqni Currently Reviewing Adoption of Block Chain Technologies
http://www.marketwatch.com/story/novateqni-currently-reviewing-adoption-of-block-chain-technologies-and-provides-corporate-update-2017-09-27
Additionally, the company has been reviewing blockchain technologies that would be synergistic to Novateqni's existing business verticals. The markets for blockchain can be anywhere from biometrics based payments and secure money transfer to voter registration, voting and voter verification. It is also potentially useful for pre payments for utilities and services.
Biometrics Infusion into Blockchain Technology is Pushing Mobile Payments and Bitcoin Industries to New Levels
http://www.crossroadstoday.com/story/36463672/biometrics-infusion-into-blockchain-technology-is-pushing-mobile-payments-and-bitcoin-industries-to-new-levels
19 Industries The Blockchain Will Disrupt
http://futurethinkers.org/industries-blockchain-disrupt/
$NTQ $NVTQF is for real, real rev and are already in the security industry / Biometrics
NovaTeqni to Provide Biometric Tech for Mobizent
https://findbiometrics.com/novateqni-biometric-mobizent-408104/
NovaTeqni Receives Custom Biometrics Product Order For The United States Of America
http://www.marketwatch.com/story/novateqni-receives-custom-biometrics-product-order-for-the-united-states-of-america-2017-08-08
* The float is amazing, 32 million shares out and CEO owns 13 Million !!
* current market cap is a joke 10 million compared to the sh*t out there trading 3x and have nothing
Today we cleaned out some tired hands but not much left and game is on
NOW we are talking BLOCKCHAIN !!!
Biometrics Infusion into Blockchain Technology is Pushing Mobile Payments and Bitcoin Industries to New Levels
http://money.cnn.com/news/newsfeeds/articles/prnewswire/enUK201709275918.htm